T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
St. Louis, April 13, 2018 -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 first quarter financial results on Wednesday, May 2, 2018, after the market closes. Management will not be holding a conference call to review results.
A copy of the earnings release will be available at the Investor Information section of Express Scripts’ web site at http://www.express-scripts.com/corporate.
About Express Scripts
Express Scripts puts medicine within reach by practicing pharmacy smarter – taking bold action, delivering specialized care, creating innovative solutions and leveraging data insights - to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President Investor Relations (314) 810-3115 [email protected]
